Shawn A. Anderson

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability.

Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability.

Journal: Cancer research

Published: July 09, 2020

Well-Differentiated Papillary Mesothelioma of the Peritoneum Is Genetically Distinct from Malignant Mesothelioma.

Well-Differentiated Papillary Mesothelioma of the Peritoneum Is Genetically Distinct from Malignant Mesothelioma.

Journal: Cancers

Published: May 17, 2020

Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target.

Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target.

Journal: Cancer cell international

Published: October 19, 2018

BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma.

BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma.

Journal: Genome medicine

Published: August 20, 2018

Management of Suspected Tension Pneumothorax in Tactical Combat Casualty Care: TCCC Guidelines Change 17-02.

Management of Suspected Tension Pneumothorax in Tactical Combat Casualty Care: TCCC Guidelines Change 17-02.

Journal: Journal of special operations medicine : a peer reviewed journal for SOF medical professionals

Published: June 01, 2018

HIT'nDRIVE: patient-specific multidriver gene prioritization for precision oncology.

HIT'nDRIVE: patient-specific multidriver gene prioritization for precision oncology.

Journal: Genome research

Published: January 31, 2017

Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer.

Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer.

Journal: European urology

Published: December 14, 2016

Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy.

Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy.

Journal: Scientific reports

Published: October 06, 2016

Differences in MEK inhibitor efficacy in molecularly characterized low-grade serous ovarian cancer cell lines.

Differences in MEK inhibitor efficacy in molecularly characterized low-grade serous ovarian cancer cell lines.

Journal: American journal of cancer research

Published: September 17, 2016

Condoms and sexual health education as evidence: impact of criminalization of in-call venues and managers on migrant sex workers access to HIV/STI prevention in a Canadian setting.

Condoms and sexual health education as evidence: impact of criminalization of in-call venues and managers on migrant sex workers access to HIV/STI prevention in a Canadian setting.

Journal: BMC international health and human rights

Published: March 01, 2016

Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies.

Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies.

Journal: Oncotarget

Published: February 10, 2015

Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer.

Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 14, 2014

Showing 1-12 of 19

Last Updated: 09/26/2026